Cambridge Healthtech Institute’s 2nd Annual
SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact
January 18, 2027
In partnership with
Join us for a forward-looking symposium exploring the evolving life of a peptide across modern drug discovery and therapeutic development. From early discovery, de novo design, and AI-enabled optimization through translational advancement and clinical application, this program highlights how emerging technologies and converging modalities are reshaping the future of peptide therapeutics. The Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Symposium convenes leaders across academia, biotechnology, and pharmaceutical research to discuss advances in antimicrobial peptides, intracellualr protein–protein interaction targets, lesson learned from targeting extracellular biology, radiopharmaceutical conjugates, targeted delivery systems, and next-generation discovery platforms. Emphasis will be placed on how cross-disciplinary integration across chemistry, biology, computational design, screening technologies, and translational sciences is accelerating peptide innovation and expanding the therapeutic reach of peptide modalities.
Whether revisiting peptides with a fresh perspective or actively developing next-generation therapeutics, attendees will gain practical insights into the scientific, technological, and translational advances driving the next era of peptide drug hunting.
Coverage will include, but is not limited to:
- AI-Enabled Peptide Discovery and de novo Design
- Emerging Therapeutic Modalities and Modality Convergence
- Peptides for Protein-Protein Interaction Targets
- Antimicrobial and Anti-Infective Peptide Therapeutics
- Radiopharmaceuticals, Conjugates, and Targeted Delivery Systems
- Extracellular and Difficult-to-Drug Targets
- Translational Strategies and Clinical Advancement of Peptide Therapeutics
- Next-Generation Discovery Technologies and Screening Platforms
The deadline for priority consideration is June 26, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: